Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel C Bird

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|April 22, 2005
Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?Martin D Gough, Roger Ackroyd, Ali W Majeed, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?Anne Smythe, Nigel C Bird, Gill P Troy, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Effects of pro-inflammatory cytokines on the production of soluble fractalkine and ADAM17 by HepG2 cellsSharon L Turner, David Mangnall, Nigel C Bird, et al.
International Journal of Oncology|June 28, 2012
Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell linesSharon L Turner, David Mangnall, Nigel C Bird, et al.
Clinical & Experimental Metastasis|April 6, 2012
The histological growth pattern of colorectal cancer liver metastases has prognostic valueGert G Van den Eynden, Nigel C Bird, Ali W Majeed, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 19, 2007
The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinomaErica di Martino, Laura J Hardie, Christopher P Wild, et al.
Cancer Research|March 29, 2013
The multifaceted role of the microenvironment in liver metastasis: biology and clinical implicationsGert G Van den Eynden, Ali W Majeed, Martin Illemann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomizationAaron P Thrift, Harvey A Risch, Lynn Onstad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 18, 2015
A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagusJames Y Dai, Jean de Dieu Tapsoba, Matthew F Buas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 14, 2015
Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma riskEunjung Lee, Daniel O Stram, Weronica E Ek, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|April 22, 2005
Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?Martin D Gough, Roger Ackroyd, Ali W Majeed, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?Anne Smythe, Nigel C Bird, Gill P Troy, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Effects of pro-inflammatory cytokines on the production of soluble fractalkine and ADAM17 by HepG2 cellsSharon L Turner, David Mangnall, Nigel C Bird, et al.
International Journal of Oncology|June 28, 2012
Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell linesSharon L Turner, David Mangnall, Nigel C Bird, et al.
Clinical & Experimental Metastasis|April 6, 2012
The histological growth pattern of colorectal cancer liver metastases has prognostic valueGert G Van den Eynden, Nigel C Bird, Ali W Majeed, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 19, 2007
The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinomaErica di Martino, Laura J Hardie, Christopher P Wild, et al.
Cancer Research|March 29, 2013
The multifaceted role of the microenvironment in liver metastasis: biology and clinical implicationsGert G Van den Eynden, Ali W Majeed, Martin Illemann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomizationAaron P Thrift, Harvey A Risch, Lynn Onstad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 18, 2015
A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagusJames Y Dai, Jean de Dieu Tapsoba, Matthew F Buas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 14, 2015
Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma riskEunjung Lee, Daniel O Stram, Weronica E Ek, et al.
Pageof 4